Telegraph Hill Partners — 2015 Investments
2 investments dated 2015 · listed companies and verified rows first · show all
Magstim develops neurotechnology and neurostimulation devices for healthcare providers and researchers, focusing on neuromodulation and neurophysiology applications.
Deep TechHardwareHealthtechMedical DevicesMental HealthSan Francisco, US
BoardThomas A. Raffin(Executive Officer, Director)J. Matthew Mackowski(Executive Officer, Director)
Develops tools to formulate and manufacture nanoparticles used as medicines; acquired by Danaher in 2021.
BiotechVancouver
Euan Ramsay(Executive Officer)inJames Taylor(Founder)inAndrew Booth(Director)R. James Taylor(Executive Officer, Director)Joe Victor(Executive Officer, Director)Daniel Nixon(Director)
Board seatDeval Lashkari· per SEC Form D
Co-investorsBDC Industrial Innovation Venture FundInnovative Solutions CanadaPage One VenturesRising Tide5AM Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




